QuadMedicine, Inc. (KOSDAQ:464490)
South Korea · Delayed Price · Currency is KRW 14,950
+190 (1.29%)
At close: Jan 28, 2026
QuadMedicine Market Cap
QuadMedicine has a market cap or net worth of 162.98 billion as of January 29, 2026.
Market Cap
162.98B
Enterprise Value
166.07B
Revenue
13.11B
Ranking
n/a
PE Ratio
n/a
Stock Price
14,950.00
Market Cap Chart
Since December 12, 2025, QuadMedicine's market cap has decreased from 199.95B to 162.98B, a decrease of -18.49%. That is a compound annual growth rate of -79.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 169.55B | -4.11% |
| Dec 30, 2025 | 176.81B | -11.57% |
| Dec 12, 2025 | 199.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prestige Biologics | 233.26B |
| Kangstem Biotech | 202.22B |
| Bio Solution | 192.90B |
| Ensol Biosciences | 187.72B |
| curacle co.,ltd. | 186.77B |
| CORESTEMCHEMON | 171.45B |
| ViGenCell | 169.94B |
| TiumBio | 168.05B |